This newslink doesn't exist or it was removed.
Go to Homempage.
ABC7 USA Health October 24, 2023
is reviewing an application for the nasal spray vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday.The vaccine, the only nasal spray option against flu, has been on the market in the United States since 2003. AstraZeneca has asked the... + más
When is the best time to get a flu shot? And what kind should I get? | Los Angeles Times
Flu shot myths make us sick — experts bust 6 of the major ones | New York Post
The Boston Globe USA Business June 14, 2023
ENERGYAstraZeneca signs deal with Waltham-based firm for renewable natural gasVanguard Renewables has signed a contract with drug giant AstraZeneca to deliver renewable natural gas to all of AstraZeneca’s 12 sites in the United States. Waltham-based Vanguard is developing... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Thursday, March 9 | Orlando Sentinel
CBS News USA Politics April 28, 2023
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after promising early results suggested it may work against all known variants of... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld | NBC News
Time USA Health October 31, 2022
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection.... + más
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Ars Technica USA Science October 12, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
About iurex | Privacy Policy | Disclaimer |